ANXA5 and cancer: According to this purpose, it has been demonstrated that ANXA5 may improve specific cancer cell targeting when combined with different therapeutic strategies, such as phototermal nanotubes (McKernan et al., 2021), vaccine antigens (Kang et al., 2020), or enzyme-prodrug systems (Virani et al., 2018).